Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 23 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Trakatelli, M [Clear All Filters]
The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities..
J Eur Acad Dermatol Venereol. 34(10), e543-e545.
(2020). Cutaneous squamous cell carcinoma with incomplete margins demonstrate higher tumour grade on re-excision..
J Eur Acad Dermatol Venereol. 34(7), 1478-1481.
(2020). The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force..
J Eur Acad Dermatol Venereol. 34(10), 2183-2197.
(2020). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version..
J Eur Acad Dermatol Venereol. 32(1), 11-22.
(2018). CONSENSUS REPORT: Recognizing non-melanoma skin cancer, including actinic keratosis, as an occupational disease - A Call to Action..
J Eur Acad Dermatol Venereol. 30 Suppl 3, 38-45.
(2016). Farmers develop more aggressive histologic subtypes of basal cell carcinoma. Experience from a Tertiary Hospital in Northern Greece..
J Eur Acad Dermatol Venereol. 30 Suppl 3, 17-20.
(2016). [Management of non melanoma skin cancer by the general practitioner]..
Rev Med Brux. 37(4), 212-220.
(2016). Non-melanoma skin cancer by solar UV: the neglected occupational threat..
J Eur Acad Dermatol Venereol. 30 Suppl 3, 3-4.
(2016). Skin cancer risk in outdoor workers: a European multicenter case-control study..
J Eur Acad Dermatol Venereol. 30 Suppl 3, 5-11.
(2016). Rare benign tumours of the nipple..
J Eur Acad Dermatol Venereol. 29(1), 7-13.
(2015). Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma..
Br J Dermatol. 170(4), 809-15.
(2014). Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population..
Br J Dermatol. 171(4), 832-8.
(2014). Assessing physicians' preferences on skin cancer treatment in Europe..
Br J Dermatol. 167 Suppl 2, 29-35.
(2012). Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future..
Br J Dermatol. 167 Suppl 2, 99-104.
(2012). Health literacy, sunscreen and sunbed use: an uneasy association..
Br J Dermatol. 167 Suppl 2, 14-21.
(2012). Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study..
Br J Dermatol. 167 Suppl 2, 1-13.
(2012). The patient journey: a report of skin cancer care across Europe..
Br J Dermatol. 167 Suppl 2, 43-52.
(2012). Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050..
Br J Dermatol. 167 Suppl 2, 53-62.
(2012). Risk factors for actinic keratosis in eight European centres: a case-control study..
Br J Dermatol. 167 Suppl 2, 36-42.
(2012). The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010..
J Eur Acad Dermatol Venereol. 25(12), 1455-65.
(2011). S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents..
Br J Dermatol. 164(1), 5-15.
(2011). Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients..
Int J Immunopathol Pharmacol. 23(2), 387-96.
(2010). Photodermatoses with onset in the elderly..
Br J Dermatol. 161 Suppl 3, 69-77.
(2009).